scholarly journals A suspected adverse drug reaction caused by human-label cyclosporine in a dog with canine atopic dermatitis

2020 ◽  
Vol 26 (3) ◽  
pp. 147-149
Author(s):  
Yukina Sugiyama ◽  
Tomoyuki Kawai ◽  
Ryuji Araki ◽  
Kazunori Ueda
Keyword(s):  
Adverse Drug Reaction ◽  
Atopic Dermatitis ◽  
Drug Reaction ◽  
Suspected Adverse Drug Reaction ◽  
Canine Atopic Dermatitis

Suspected adverse drug reaction reports with oral anticoagulants in Portugal: a pharmacovigilance study

2018 ◽  
Vol 17 (4) ◽  
pp. 339-345 ◽  
Author(s):  
Daniel Caldeira ◽  
Raquel Rodrigues ◽  
Daisy Abreu ◽  
Ana Marta Anes ◽  
Mário M. Rosa ◽  
...  
Keyword(s):  
Adverse Drug Reaction ◽  
Drug Reaction ◽  
Oral Anticoagulants ◽  
Suspected Adverse Drug Reaction

912: DETERMINING CAUSALITY FOR SUSPECTED ADVERSE DRUG REACTION-RELATED ICU ADMISSIONS

2016 ◽  
Vol 44 (12) ◽  
pp. 304-304
Author(s):  
Jaclyn LeBlanc ◽  
Pamela Smithburger ◽  
Shawn Kram ◽  
Sandra Kane-Gill
Keyword(s):  
Adverse Drug Reaction ◽  
Drug Reaction ◽  
Suspected Adverse Drug Reaction

scholarly journals Enhancing Communication about Paediatric Medicines: Lessons from a Qualitative Study of Parents' Experiences of Their Child's Suspected Adverse Drug Reaction

PLoS ONE ◽  
2012 ◽  
Vol 7 (10) ◽  
pp. e46022 ◽  
Author(s):  
Janine Arnott ◽  
Hannah Hesselgreaves ◽  
Anthony J. Nunn ◽  
Matthew Peak ◽  
Munir Pirmohamed ◽  
...  
Keyword(s):  
Adverse Drug Reaction ◽  
Drug Reaction ◽  
Qualitative Study ◽  
Suspected Adverse Drug Reaction ◽  
Paediatric Medicines ◽  
Parents Experiences

scholarly journals Acute Pustular Dermatosis, Following Topical Treatment With Pimecrolimus, in a Child Affected With Atopic and Contact Hand Dermatitis

2016 ◽  
Vol 21 (1) ◽  
pp. 81-84
Author(s):  
Dimitri Poddighe ◽  
Valeria Brazzelli ◽  
Amelia Licari ◽  
Gian Luigi Marseglia
Keyword(s):  
Adverse Drug Reaction ◽  
Atopic Dermatitis ◽  
Drug Reaction ◽  
Risk Factor ◽  
Topical Treatment ◽  
Leukocytoclastic Vasculitis ◽  
Important Risk Factor ◽  
Hand Dermatitis ◽  
Clinical Indications

Atopic dermatitis is considered an important risk factor for chronic hand dermatitis, which can be seen in children too. Pimecrolimus cream 1% is approved to treat atopic dermatitis in children aged 2 years or older. In adults, this drug has been used for some clinical indications other than atopic dermatitis, such as chronic hand dermatitis. Here, we describe an adverse drug reaction in a 2-year-old child affected with atopic dermatitis, who was treated with topical pimecrolimus in order to ameliorate her concomitant hand dermatitis. The use of topical pimecrolimus led to a previously undescribed hand pustular dermatosis, being consistent with a form of pustular leukocytoclastic vasculitis, which required the permanent discontinuation of topical pimecrolimus.

scholarly journals G25 Communicating with parents following a suspected adverse drug reaction in a child: who says what and when?

2015 ◽  
Vol 100 (Suppl 3) ◽  
pp. A10.3-A11
Author(s):  
J Arnott ◽  
AJ Nunn ◽  
H Mannix ◽  
M Peak ◽  
M Pirmohamed ◽  
...  
Keyword(s):  
Adverse Drug Reaction ◽  
Drug Reaction ◽  
Suspected Adverse Drug Reaction

Evaluation of Completeness of Suspected Adverse Drug Reaction Reports Submitted to the Mexican National Pharmacovigilance Centre

Drug Safety ◽  
2012 ◽  
Vol 35 (10) ◽  
pp. 837-844 ◽  
Author(s):  
Betsabé Sánchez-Sánchez ◽  
Marina Altagracia-Martínez ◽  
Jaime Kravzov-Jinich ◽  
Consuelo Moreno-Bonett ◽  
Everardo Vázquez-Moreno ◽  
...  
Keyword(s):  
Adverse Drug Reaction ◽  
Drug Reaction ◽  
Suspected Adverse Drug Reaction ◽  
Pharmacovigilance Centre ◽  
National Pharmacovigilance Centre
Sign in / Sign up

Export Citation Format

Share Document